Yonsei Med J.  2015 Jan;56(1):309-310. 10.3349/ymj.2015.56.1.309.

Does Liver Resection Provide Long-Term Survival Benefits for Breast Cancer Patients with Liver Metastasis? A Question Yet to Be Answered

• Lee SY
• Sadot E

• KMID: 2352824
• DOI: http://doi.org/10.3349/ymj.2015.56.1.309

Abstract

No abstract available.

MeSH Terms

Breast Neoplasms/*complications/*surgery
Female
Humans
Liver Neoplasms/*secondary/*surgery
Male

Reference

1. Kim JY, Park JS, Lee SA, Kim JK, Jeong J, Yoon DS, et al. Does liver resection provide long-term survival benefits for breast cancer patients with liver metastasis? A single hospital experience. Yonsei Med J. 2014; 55:558–562.

2. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg. 2006; 244:897–907.

3. Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, et al. Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg. 2012; 214:769–777.

4. Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer. 2011; 47:2282–2290.

5. Weinrich M, Weiß C, Schuld J, Rau BM. Liver resections of isolated liver metastasis in breast cancer: results and possible prognostic factors. HPB Surg. 2014; 2014:893829.

6. Dafni U, Grimani I, Xyrafas A, Eleftheraki AG, Fountzilas G. Fifteen-year trends in metastatic breast cancer survival in Greece. Breast Cancer Res Treat. 2010; 119:621–631.

7. Martinez SR, Young SE, Giuliano AE, Bilchik AJ. The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg. 2006; 191:281–283.